Commonwealth Equity Services’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-10,301
| Closed | -$22K | – | 2521 |
|
|
2016
Q4 | $22K | Sell |
10,301
-3,409
| -25% | -$7.28K | ﹤0.01% | 2288 |
|
|
2016
Q3 | $46K | Sell |
13,710
-51,840
| -79% | -$174K | ﹤0.01% | 2172 |
|
|
2016
Q2 | $206K | Sell |
65,550
-6,656
| -9% | -$20.9K | ﹤0.01% | 1938 |
|
|
2016
Q1 | $240K | Buy |
72,206
+1,623
| +2% | +$5.4K | ﹤0.01% | 1791 |
|
|
2015
Q4 | $250K | Sell |
70,583
-9,746
| -12% | -$34.5K | ﹤0.01% | 1738 |
|
|
2015
Q3 | $404K | Buy |
80,329
+7,863
| +11% | +$39.5K | ﹤0.01% | 1366 |
|
|
2015
Q2 | $466K | Buy |
72,466
+10,562
| +17% | +$67.9K | ﹤0.01% | 1372 |
|
|
2015
Q1 | $435K | Buy |
61,904
+8,269
| +15% | +$58.1K | ﹤0.01% | 1403 |
|
|
2014
Q4 | $414K | Sell |
53,635
-3,170
| -6% | -$24.5K | ﹤0.01% | 1379 |
|
|
2014
Q3 | $424K | Sell |
56,805
-13,399
| -19% | -$100K | 0.01% | 1352 |
|
|
2014
Q2 | $680K | Buy |
70,204
+7,756
| +12% | +$75.1K | 0.01% | 1075 |
|
|
2014
Q1 | $519K | Buy |
62,448
+20,843
| +50% | +$173K | 0.01% | 1139 |
|
|
2013
Q4 | $351K | Buy |
41,605
+24,741
| +147% | +$209K | 0.01% | 1344 |
|
|
2013
Q3 | $134K | Buy |
16,864
+634
| +4% | +$5.04K | ﹤0.01% | 1723 |
|
|
2013
Q2 | $125K | Buy |
+16,230
| New | +$125K | ﹤0.01% | 1664 |
|